NICE guidelines for type 2 diabetes (NG28) recommend reviewing GLP-1 treatment at around 6 months and continuing only if there has been a meaningful reduction in HbA1c (typically at least 11 mmol/mol [1%]) and weight loss of at least 3% of initial body weight
Sirt5 exclusively removes negatively-charged acyl groups, while Sirt1/2/3/6/7 preferentially remove hydrophobic acyl groups
Why this matters: Higher doses slow digestion more aggressively Sudden appetite suppression can shock your system Increases risk of nausea, fatigue, and dizziness What to do: Follow a gradual dosage plan Stay at each dose level until your body adapts Never increase dose just to speed up weight loss Key Insight: Slower progression = fewer side effects + better long-term results 2
16 Dysfunction in brain cell types Inflammation is tightly tied to conditions such as Alzheimers disease, Parkinsons disease, and other dementias
Proc Natl Acad Sci USA 2010;107:878893
Peng D, Hu T, Soutto M, Belkhiri A, Zaika A, El-Rifai W